← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1326	Polar Asset Management Partners Toronto, Ontario, Canada	$0	-$117K	0	–	Closed
1327	PCM Potomac Capital Management New York	$0	-$445K	0	–	Closed
1328	PCM Proxima Capital Management New York	$0	-$1.18M	0	–	Closed
1329	Rafferty Asset Management New York	$0	-$303K	0	–	Closed
1330	RC Roundview Capital Princeton, New Jersey	$0	-$3.08M	0	–	Closed
1331	Ruane, Cunniff & Goldfarb New York	$0	-$732K	0	–	Closed
1332	SFU Stonehage Fleming (UK) London, United Kingdom	$0	-$19K	0	–	Closed
1333	SCA Strategic Capital Alternatives Gig Harbor, United States	$0	-$67K	0	–	Closed
1334	TFO Tarbox Family Office Newport Beach, California	$0	-$103K	0	–	Closed
1335	TWA Tillar-Wenstrup Advisors Centerville, Ohio	$0	-$2.48M	0	–	Closed
1336	TNBTD Trustmark National Bank Trust Department Jackson, Mississippi	$0	-$357K	0	–	Closed
1337	VAM Visionary Asset Management Houston, Texas	$0	-$2K	0	–	Closed
1338	VVP Vulcan Value Partners Birmingham, Alabama	$0	-$28K	0	–	Closed
1339	Walleye Trading New York	$0	-$12K	0	–	Closed
1340	WI WBI Investments Red Bank, New Jersey	$0	-$18.1M	0	–	Closed
1341	Wealthfront Palo Alto, California	$0	-$1.94K	1	0%	Reduced
1342	ZDA Zweig-DiMenna Associates New York	$0	-$2.63M	0	–	Closed